FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ZELICAPAVIR
异名/同义词(3S)-3-((5-(3-(MORPHOLIN-4-YL)-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)-1,3,4-OXADIAZOL-2-YL)AMINO)-5-PHENYL-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE
(S)-3-((5-(3-MORPHOLINO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)-1,3,4-OXADIAZOL-2-YL)AMINO)-5-PHENYL-1,3-DIHYDRO-2H-BENZO(E)(1,4)DIAZEPIN-2-ONE
2H-1,4-BENZODIAZEPIN-2-ONE, 1,3-DIHYDRO-3-((5-(3-(4-MORPHOLINYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINYL)-1,3,4-OXADIAZOL-2-YL)AMINO)-5-PHENYL-, (3S)-
EDP-938
ZELICAPAVIR
ZELICAPAVIR [INN]
ZELICAPAVIR [USAN]
ZELICAPAVIR [WHO-DD]
CAS登记号2070852-76-3
物质唯一标识(Unique Ingredient Identifier)U4OI721DMD
分子式
国际化合物标识(International Chemical Identifier,InChI)C27H22F3N7O3
SMILESVGGNPZNYTJXPEW-HSZRJFAPSA-N
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型C(F)(F)(F)c1cc(c(nc1)-c2oc(nn2)N[C@H]3N=C(c4c(NC3=O)cccc4)c5ccccc5)N6CCOCC6 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System